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Abstract
Rpn13 is a novel mammalian proteasomal receptor that has recently been identified as an amplification target in ovarian
cancer. It can interact with ubiquitin and activate the deubiquitinating enzyme Uch37 at the 26S proteasome. Since neither
Rpn13 nor Uch37 is an integral proteasomal subunit, we explored whether either protein is essential for mammalian
development and survival. Deletion of Uch37 resulted in prenatal lethality in mice associated with severe defect in
embryonic brain development. In contrast, the majority of Rpn13-deficient mice survived to adulthood, although they were
smaller at birth and fewer in number than wild-type littermates. Absence of Rpn13 produced tissue-specific effects on
proteasomal function: increased proteasome activity in adrenal gland and lymphoid organs, and decreased activity in testes
and brain. Adult Rpn13
2/2 mice reached normal body weight but had increased body fat content and were infertile due to
defective gametogenesis. Additionally, Rpn13
2/2 mice showed increased T-cell numbers, resembling growth hormone-
mediated effects. Indeed, serum growth hormone and follicular stimulating hormone levels were significantly increased in
Rpn13
2/2 mice, while growth hormone receptor expression was reduced in the testes. In conclusion, this is the first report
characterizing the physiological roles of Uch37 and Rpn13 in murine development and implicating a non-ATPase
proteasomal protein, Rpn13, in the process of gametogenesis.
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Introduction
The Rpn13 protein, previously termed adhesion-regulating
protein 1 or GP110, has been identified as a tumor-associated gene
product [1,2,3,4,5,6], and more recently as an amplification target
in ovarian cancer [7]. Initially, Rpn13 was suggested to regulate
cell adhesion as a membrane-associated protein [2], but further
examination revealed that it is primarily a cytosolic protein
associated with proteasomes [8]. Proteasomes are central molec-
ular complexes of the non-lysosomal, ubiquitin-ATP-dependent
protein degradation pathway. Independent studies demonstrated
direct interaction of Rpn13 with ubiquitin and the deubiquitinat-
ing enzyme Uch37 (also termed UchL5) [9,10], as well as with the
proteasome subunit Rpn2/S1 [11,12]. Binding of Rpn13 to
Uch37 increases the isopeptidase activity of Uch37; therefore it
may facilitate the rescue of ubiquitinated substrates from
proteolysis [9,10,13]. Thus, Rpn13 is emerging as a potentially
important docking/coupling protein with a regulatory function in
recognition and disassembly of ubiquitinated proteins at the
proteasome.
Most of the reports on the physiological significance of Rpn13
and Uch37 function concluded that neither protein was essential
for cell survival. Inactivation of all known ubiquitin receptors,
including Rpn13, in yeast cells did not induce cell death [12].
Likewise, expression of the Uch37 homologue, Uch2, in fission yeast
was not required for survival [14]. Viability of the human HeLa
cell line, was also unaffected by knocking down expression of
Rpn13 [15] or Uch37 [16]. Overexpression of Rpn13 was reported
to increase the adherence of 293T cells [2], as well as human
natural killer (NK) and T cells [8], to endothelial cells. However,
one study found that overexpression of the C-terminal domain of
Rpn13 that modifies Uch37 function, led to cell death in the 293T
cell line [10]. To our knowledge, only Rpn13 was studied in a
higher organism, the frog, where the Rpn13 homologue, Xoom was
indispensable for survival of frog embryos [17].
Biochemical measurements reported to date are not conclusive
about the contribution of Rpn13 and Uch37 to the function of the
proteasome. In HeLa cells, knockdown of Rpn13 did not affect the
amount of proteasome, degradation of proteins, or the accumu-
lation of ubiquitinated proteins [15]. In sharp contrast, Rpn13
siRNA decreased proteasome function in 293T cells and increased
the ubiquitinated protein content, however overexpression of
Rpn13 had a similar effect [10]. Uch37 knockdown in the same cell
line led to decreased deubiquitination activity [9,10] and
expression of the C-terminal domain of Rpn13, that competes
for the binding to Uch37, reduced proteolytic activity [9,10].
We generated Rpn13 and Uch37 knockout (KO) mice and
performed comprehensive phenotypic analyses to delineate the
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physiology. The results indicate differing roles for Rpn13 and
Uch37 in mammalian development and furthermore define a
requirement for Rpn13 in gametogenesis.
Results
Uch37 and Rpn13 are both essential in early mouse
development
Uch37- and Rpn13-null mice were derived from the OmniBank
[18,19] embryonic stem cell clones OST447189 and OST128063,
respectively. Inverse genomic PCR of DNA isolated from Uch37
embryonic stem cells revealed that the gene-trap vector had
inserted in intron 1 downstream of the first coding exon of the
mouse Uchl5 gene which encodes Uch37 (Figure 1A) and was
confirmed by genomic PCR analysis (Figure 1B). The Rpn13
clone carried a gene trap mutation within the second intron of the
Rpn13 gene encoding Rpn13 (Figure 1A). Inactivation of Rpn13
gene in KO mice was confirmed by genomic PCR (Figure 1B),
expression analysis of the gene transcript (Figure 1C), and by
immunohistochemical (IHC) staining with a mAb to the Rpn13
protein (Figure 1D). Presence of Rpn13 transcript was detected
only in Wt and not in KO tissues (Figure 1C), while expression of
genes immediately flanking Rpn13 (Lama5 and Osbpl2) was not
affected by the Rpn13 deletion (Figure 1E). The silencing of Uch37
did not affect the expression levels of Rgs2 and Trov2 that flank the
Uch37 gene (Figure 1E).
Heterozygous mice (Uch37
+/2 and Rpn13
+/2) were fertile and
were intercrossed to obtain homozygous progeny. Complete
deletion of Uch37 resulted in prenatal lethality, since no
homozygous neonates were identified among 64 pups produced
by 10 litters of Uch37
+/2 mice. Timed breeding of Uch37
+/2 mice
showed that Uch37
2/2 embryos were underdeveloped and were
undergoing resorption from as early as day 8.5. The few Uch37
2/2
embryos that we were able to analyze at 13.5 days post-conception
showed that the decreased viability of mutant mice was most likely
due to severe developmental defects of the brain (Figure 2). The
developmental lesions in the brain were characterized by the
Figure 1. Generation of Uch37 and Rpn13 mutant mice. (A) Gene trap mutation and location of primers for genotyping strategy and expression
analysis of the Uch37 and Rpn13 genes. Arrows and arrowheads indicate transcription start sites. Primers A–D were used to identify the insertion site
by nested PCR in the Uch37 clone. Primers E and F flank the genomic insertion site in the Rpn13 gene and amplify a product for the Wt allele. The
LTR2 primer, complementary to the gene-trapping vector, amplifies the mutant allele in conjunction with primer H. SA, splice acceptor sequence;
LTR, viral long terminal repeat; Neo, neomycin resistance gene. (B) Genotypic analysis of mice at the Uch37 and Rpn13 loci was performed by
screening genomic DNA isolated from embryos and tail biopsy samples respectively. (C) Indicated gene transcripts were detected in the designated
tissues by RT-PCR using primers G and H. (D) IHC was performed using the designated mAbs on the indicated thymus sections. (E) Expression analysis
of Rpn13, Uch37 (in 13.5 days old embryos) and their respective neighboring genes. Indicated gene transcripts were detected by RT-PCR.
doi:10.1371/journal.pone.0013654.g001
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lateral ventricles, resulting in a wide range of defects in the
formation of the telencephalon, mesencephalon and metenceph-
alon. Disorganized neuronal growth was most evident in the area
of the forebrain, cerebellum, and midbrain, with formation of
irregular neuronal rosettes and folds in place of the normal
periventricular laminae (Figure 2). In contrast, breeding of
Rpn13
+/2 mice resulted in the production of 276 viable
homozygous mutant mice out of 1935 progeny, with none
displaying any clear developmental neurological lesions. Never-
theless, the ratios of the three possible genotypes at the age of 3
weeks significantly deviated from the normal Mendelian (1:2:1)
distribution (29.6% wild-type (Wt; Rpn13
+/+), 56.2% Rpn13
+/2,
and 14.3% knockout (Rpn13
2/2); p=8610
227). This genetic
deviation was not due to reduced viability of Rpn13
2/2 embryos
since examining the embryonic development of Rpn13
2/2 mice at
8.5, 10.5, 11.5 and 13.5 embryonic age did not reveal any clear
alterations in Mendelian ratios or pathological abnormalities that
could explain the reduced number of Rpn13-deficient mice (not
shown). However, Rpn13
2/2 newborns were smaller at birth and
as such were less competitive with their Wt and Het siblings for
food which could explain their reduced numbers when they
reached 3 weeks of age for genotyping. Indeed, we observed that
removing the bigger siblings enhanced the chances of Rpn13
2/2
mice to survive (data not shown).
Rpn13 protein exhibits differential expression and
function in vivo
IHC staining with an anti-Rpn13 monoclonal antibody (mAb)
indicated that the Rpn13 protein was present in all Wt tissues
examined: thymus (Figure 1D), brain, spleen (Figure 3), adipose,
adrenal, cardiac and skeletal muscle, cartilage, gastrointestinal
tract, liver, lung, mammary gland, ovary, pancreas, salivary gland,
and thyroid (data not shown). However, the staining pattern of
Rpn13 was rather cell-type specific as illustrated by the positive
staining of Purkinje cells but not the granular layer in the
Figure 2. Uch37-deficient embryos show defects in brain development. Histological examination of 13.5 days old embryos revealed that,
when compared to age-matched Wt embryos, Uch37
2/2 mice showed undeveloped lateral and third ventricles in forebrain area, with associated
disorganized development of cortex and midbrain as well as undeveloped mesencephalic vesicle and fourth ventricles in midbrain, with disorganized
development of cerebellum and hindbrain.
doi:10.1371/journal.pone.0013654.g002
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to weak positive staining of the B-cell areas of the spleen (Figure 3).
No specific staining was evident in Rpn13
2/2 tissues (Figure 1D
and 3).
Measurement of Rpn13-associated enzyme activities in KO
mice also demonstrated differential, tissue-specific effects of Rpn13
deletion. Rpn13 has been identified as a component of the
proteasome pathway [10,15]. Therefore we performed compara-
tive measurements of the trypsin-like, chymotrypsin-like, and
caspase-like activities of the proteasome in tissue extracts from
Rpn13
2/2, Rpn13
+/2 and Rpn13
+/+ mice. All proteasome
functions were significantly decreased in the testes of Rpn13
2/2
mice when compared to Wt littermates (Figure 4). On the other
hand, the same activities were significantly increased in the
adrenal gland and thymus, and with the exception of trypsin-like
activity, in the spleen of Rpn13
2/2 mice. Brain tissues from
Rpn13
2/2 mice showed a modest decrease in proteasome function
but reached statistical significance only for trypsin-like activity
(Figure 4 upper panel). In contrast, proteasomal activities in the
liver, ovaries, and kidneys were not affected by the Rpn13 deletion.
Rpn13 is indispensable for normal spermatogenesis and
oogenesis
Rpn13
2/2 mice, along with their Wt littermates, were subjected
to our standard phenotypic evaluation protocol, which is an
integrated suite of medical diagnostic procedures designed to
assess the function of the major organ systems (described in detail
in ref. [19]). The Rpn13
2/2 mice were smaller than their Wt
littermates during the first weeks of life, but both sexes reached
normal body weight by 6–8 weeks of age (Figure 5A). Independent
of body weight, gender, or age, all Rpn13
2/2 mice had
significantly higher body fat content detected by NMR analysis
(Figure 5B) and dual energy X-ray absorptiometry (DEXA) (data
not shown). CAT-scan also demonstrated increased abdominal
and subcutaneous fat depots in Rpn13
2/2 mice (Figure 5C).
Rpn13
2/2 mice are infertile since multiple attempts to breed
either male or female mice failed. Histological analysis of 12 weeks
old Rpn13
2/2 male mice revealed hypoplasia of seminiferous
tubules and azoospermia (Figure 6). Importantly, the interstitial
cells (Leydig cells) (Figure 6, upper panels), accessory sex glands,
and secondary sex characteristics in the salivary glands and kidney
(data not shown) were all normal in appearance. In 3 week old
males, the seminiferous tubules of Wt mice contained numerous
pachytene spermatids and spermatogonia, while in Rpn13
2/2
mice the seminiferous tubules were lined predominately by
hypertrophic Sertoli cells, and most of the identifiable spermatids
were early stage and undergoing apoptosis (Figure 6).
In 3 week old females, ovaries of Wt mice contained numerous
ova surrounded by deep layers of granulose cells, and numerous
primordial follicles were present. In contrast, in young female
Rpn13
2/2 mice there were relatively few ova and those present
were surrounded by a single layer of cells. Primordial follicles
could not be reliably identified in routine hematoxylin and eosin
(H&E) stained sections from 3-week old Rpn13
2/2 mice, but other
reproductive tract structures and secondary sex characteristics
appeared to be within normal limits (data not shown). In 12-week
old Rpn13
2/2 females, there were no detectable primordial
ovarian follicles or corpora lutea, and there were only a few
secondary atretic and cystic follicles present within the vacuolated
interstitial ovarian stroma when compared to Wt littermates
(Figure 6, lower panels).
Rpn13 deficiency leads to altered T-cell development
Decreased gonadal function and alterations in steroid or growth
hormone levels can impact immune system development and
function, particularly thymic output [20,21,22]. Since the overall
phenotype of Rpn13
2/2 mice was consistent with disturbed
hormonal balance in the KO animals, we performed blood cell
and immune tissue analysis. Rpn13
2/2 mice harbored significantly
higher number of CD4
+ T cells and, to a lesser extent, CD8
+ T
cells in the peripheral blood when compared to Wt littermates
(Figure 7A). In contrast, B cells, NK, monocytes, neutrophils, red
blood cells and platelets (PLT) were present at comparable levels
in the two genotypes. Correspondingly, FACS analysis of
splenocytes also showed a significant increase in the CD4/CD8
T-cell ratio (Figure 7A). Consistent with the above findings,
Rpn13
2/2 mice developed larger thymuses with more cellularity
compared to Wt mice (Figure 7A and B). However, the increased
Figure 3. The expression pattern of the Rpn13 protein is cell-type specific. IHC was performed using anti-Rpn13 mAb on the indicated
tissue sections.
doi:10.1371/journal.pone.0013654.g003
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main developmental stages of CD4/CD8 double negative (DN),
double positive (DP), and single positive (SP) cell subsets
(Figure 7C). The increased thymocyte development was not due
to clonal expansion of specific thymocyte subsets since examina-
tion of the repertoire of TCR a- and b-chain variable regions
showed similar distribution in Rpn13
2/2 and Wt thymocytes
(Figure S1). Similarly we did not observe any differences in the
proliferation of thymocytes to anti-CD3 plus IL-2 and Concanav-
alin A or their susceptibility to apoptosis by anti-CD3 induced
deletion in vivo and Dexamethasone in vitro that would explain
the increase in thymocyte population or the accumulation of CD4
T cells (not shown). Consistent with the above findings, Rpn13
2/2
did not develop signs of autoimmune disease or thymomas during
the course of our studies (up to 6 month of age).
Rpn13 is essential for normal hormonal balance
We next tested whether the observed phenotype of Rpn13
2/2
mice is associated with changes in the levels of hormones involved
in body growth and composition, sexual maturity, and thymic
development. Circulating levels of GH and FSH were significantly
elevated in the serum of Rpn13
2/2 mice compared to Wt animals
(Figure 8A). No apparent differences were observed in serum
concentrations of testosterone or cortisol between the two
genotypes. We further tested expression of GH receptor in protein
lysates of testes (Figure 8B), ovaries, thymus, and adrenal glands
(data not shown). The testes of Rpn13
2/2 mice showed severe
reduction in GH receptor protein in comparison to Wt levels while
the other tissues examined did not demonstrate significant
differences in GH receptor expression.
Discussion
Recent biochemical and genetic experiments identified the
Uch37 and Rpn13 proteins as novel proteasomal interacting
partners [9,10]. However, the functional role of these proteins in
the regulation of proteasomal activity is unclear. Knockdown
studies provided inconsistent results for readouts of either survival
or proteasome function in yeast and mammalian cell lines
[9,15,23]. Therefore we explored the physiological consequences
of loss of function of Uch37 and Rpn13 in mice. The KO
phenotypes demonstrated that, unlike Rpn13, Uch37 is essential
for prenatal development and survival, which implies different
functions for these two proteins in vivo. This is not unexpected,
since both Uch37 and Rpn13 have been implicated in distinct
molecular pathways presumably independent of their mutual
interaction. For instance, Uch37 can also associate with Rpn10
(S5a) at the proteasome complex [10,14], as well as with the
Figure 4. The effect of Rpn13 deletion on proteasome function is tissue-specific. Indicated proteasome activities were measured in protein
lysates prepared from the designated tissues (left panels), or in purified 26S preparations with or without epoxomicin as controls (right panels). For
the tissue lysates, data were obtained from 7–19 samples of each genotype pooled from at least four independent experiments giving similar results.
26S controls included 3 samples for each treatment. Enzyme activities were normalized to the mean of the Wt or control values and are presented as
mean 6 SEM. Numbers above bars indicate P values compared to Wts.
doi:10.1371/journal.pone.0013654.g004
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proteins, particularly with Smad7 [25]. Of note, Rpn10 deletion
results in early-embryonic lethality in mice [26]. Thus, it is possible
that disruption of one or more of these additional pathways leads
to lethality of the Uch37
2/2 mice. On the other hand, Uch37 may
remain active in the proteasomal complex and continue to
regulate protein deubiqutination in the absence of Rpn13.
Rpn13
2/2 mice showed only reduced viability and close to 60%
of the surviving pups reached adulthood, which enabled us to
further interrogate the in vivo function of this proteasomal receptor.
Surviving Rpn13
2/2 mice showed defective gametogenesis,
delayed growth, high fat accumulation, and altered T-cell
development. Collectively, these abnormalities are consistent with
dysregulation of hypothalamic-pituitary-gonadal axis encompass-
ing key hormonal pathways. Absence of Rpn13 expression may
have affected endocrine circuits directly or indirectly at multiple
locations since altered proteasomal function was detected in
various (but not all) organs, including testes, brain, adrenal gland,
and lymphoid tissues.
The phenotype of the Rpn13 KOs and analysis of proteasome
activities in different tissues of Rpn13
2/2 mice suggest a relatively
tissue-specific physiological role for this proteasome receptor.
Depending on where it is expressed, Rpn13 could play enhancer,
repressor, or non-critical role in regulating proteasome activity.
Contrasting activity profiles of proteasomal proteins in different
tissues is not uncommon, and is thought to reflect tissue-specific
diversity of proteasomes. Indeed, Rpn13 is not a constitutive
proteasome subunit, since only a fraction of 26S proteasomes
contain Rpn13 [9], and we observed significant cell type-specific
differences in the expression pattern of the protein in certain
tissues which might explain the seemingly contradictory data from
cell lines about Rpn13 function [9,10]. Tissue-specific functions
for proteasome complex regulators have been reported before.
PA700/19S, PA28a/b, and PA200, are molecules that associate
with the a heptameric rings of the 20S and regulate its functions
[27,28,29]. Even though these proteasomal proteins are broadly
expressed, they play different physiological roles in various tissues:
PA200 is required for normal spermatogenesis [30] while PA28a
and PA28b modulate immunoproteasome function [31]. The
developmental abnormalities in Rpn13
2/2 mice were observed in
a number of tissues, and it is likely that the absence of Rpn13 not
only impacted organ development directly by altering the
proteasome function in those tissues, but also had an indirect
effect via the neuroendocrine pathway.
Rpn13 KOs registered elevated serum concentrations of two key
hormones, GH and FSH. The testes of Rpn13
2/2 mice also
showed reduced levels of the GH receptor, whose expression was
shown previously to be modulated by proteasome function [32].
The GH-GH receptor interaction is known to have pleiotropic
effects on growth, metabolism and sexual maturation [33].
Although dysregulation of GH signaling via GH receptors is a
likely contributor to the phenotype of Rpn13
2/2 mice, it cannot
account for all aspects of it. The defect in sexual maturation of
Rpn13
2/2 mice is more severe than that of ‘‘GH-resistant’’ mice,
which are deficient in GH receptor expression and also register
elevated levels of GH [34,35,36]. However, the observed changes
in T-cell development in Rpn13
2/2 mice are highly consistent with
increased GH levels and signaling via GH receptors expressed in
the thymus. Growth hormone enhances thymopoiesis and
augments thymus volume in both rodents and humans [37].
Moreover, it stimulates the selective trafficking of CD4
+ thymic
emigrants compared to CD8
+ cells to the periphery, leading to
increased CD4/CD8 ratio in the lymphoid organs [37]. All these
effects parallel the increased thymic cellularity and overrepresen-
tation of CD4
+ cells that we found in the Rpn13
2/2 mice. Besides
GH-related effects, Rpn13 may also directly influence thymus
development, since we observed increased proteasome function in
the thymus of Rpn13
2/2 mice. In T cells, proteasomes regulate
activation, proliferation [38,39], and expression of apoptotic
factors [40]. However, transfer of Rpn13
2/2 bone marrow cells
Figure 5. Rpn13 deficiency affects body weight and composition. Body weights (A) and composition (B) were measured for the indicated
mice at the time points and intervals shown. Minimum 3, maximum 38 mice were studied at each time point. Numbers above bars indicate P values
compared to Wts. (C) Representative images of CAT-scan analysis of 16-weeks old male mice with the indicated genotype. An additional male and a
female Rpn13
2/2 mouse were also analyzed along with Wt littermates and showed similar increases in fat deposits as marked on the image.
doi:10.1371/journal.pone.0013654.g005
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phenotype (unpublished observations), which strongly suggests that
the alteration in thymus size and the accumulation of CD4
+ T cells
in the periphery are not intrinsic to T-lineage cells but likely
mediated by external factors, such as GH.
Perturbations in ovarian-pituary interactions and lack of
gonadal feedback from certain endocrine tissues may also explain
the elevation of FSH levels in the Rpn13
2/2 mice. For instance,
endocrine peptides, including inhibin, which suppresses pituitary
FSH production, are synthesized and released from the ovary and
testis in mammals. Absence of inhibin in KO mice leads to high
circulating levels of FSH [41].
Recently, Rpn13 was shown to be significantly upregulated in the
early stages of ovarian cancer and continues to increase as the
disease progresses. This increase has been correlated with highest
recurrence and metastasis [7]. Importantly, the most striking
phenotype in female Rpn13
2/2 mice was a developmental defect
in the ovaries. However, deletion of Rpn13 did not affect the overall
proteasomal activity in the ovaries themselves, suggesting that the
underlying mechanism of defective gametogenesis in the Rpn13 KO
mice may not be intrinsic to this reproductive organ but likely has
neuroendocrine origin. Alternatively, since Rpn13 is differentially
expressed by different cell types in the same tissue, it is possible that
certain cells that regulate organ development were impacted by its
absence more than others and this would not be reflected by studies
which measure proteasome function at the organ level.
In conclusion, our results demonstrate that although Uch37 and
Rpn13 have been shown to associate in many studies [9,10,13],
their physiological roles may differ considerably. Uch37 plays a
vital role in brain development early in the embryonic phase while
Rpn13 is required mainly after birth for proper growth and
maturation of the reproductive and endocrine systems. The
developmental defects and abnormalities in the reproductive and
immunological systems in Rpn13
2/2 mice likely involve pleiotro-
pic effects and feedback mechanisms intrinsic to the neuroendo-
crin pathways. Further studies aimed toward identification of
proteins whose ubiquitination patterns are affected by deletion of
Rpn13 and Uch37 could be informative for identification of
factors leading to the observed KO phenotypes and possibly
affecting tumor development. A unique characteristic of Rpn13
protein is that its absence completely blocks oogenesis and
spermatogenesis apparently without affecting secondary sex
characteristics. Investigation of the potential effect of inhibiting
Rpn13 in cancer is warranted, since it may provide avenues to
adjunct therapy of ovarian tumors or seminomas with less
disruption to estrogen or testosterone levels.
Note Added to Proof
A recent publication has provided further proof of the selective
role of Rpn13 in proteasomal function by identifying nitric oxide
synthase and IkappaB-alpha as two specific substrates of the
Rpn13/Uch37 complex [42].
Materials and Methods
Generation of Uch37 and Rpn13 mutant mice
OmniBank ES clones [18,19] were selected for microinjection
into host blastocysts based on sequence similarity to the mouse
Uch37 and Rpn13 genes (accession numbers NM_019562 and
NM_019822.3, respectively). The precise genomic insertion sites
of the gene-trapping vectors were determined by inverse genomic
PCR as described [43]. Mutant mice were generated by using
standard methods [44]. For Uch37, two rounds of PCR using
nested primers complementary to the gene trapping vector (Round
1: A: 59- GTT AAG ATC AAG GTC TTT TCA CCT GGC -39
and B: 59- CCA TAT TCA GCT GTT CCA TCT GTT CC -39;
Round 2: C: 59- GCC TCG ATC CTC CCT TTA TCC AGC -
39 and D: 59- AAA TGG CGT TAC TTA AGC TAG CTT GC-
39) were used to amplify vector-genomic junction sites. Genotyping
of mice was performed by using quantitative PCR [43]. Wt and
mutant Rpn13 alleles were amplified with oligonucleotide primers
E( 5 9-GAA AGA CAG GAC CTC TGG GAC CGT - 39), F (59-
CTG GCT AGC TGC TCC TAA GTG TAA-39), LTR2 (59-
AAA TGG CGT TAC TTA AGC TAG CTT GC-39, and H (59-
GCC GCT TGG ACC CTG CCT TAA AC-39). Wt and Uch37
mutant embryos were genotyped using P (59-TTA ATG TGA
ATA ATC GGA ATG CTG G-39) and Q (59-CTA TAC AAT
ATG GTA TCT GAT TTG G-39) to detect the Wt gene. P and
LTR-rev (59-ATA AAC CCT CTT GCA GTT GCA TC-39)
were used to detect the mutant Uch37 alleles.
Animal background and care
All mice analyzed were maintained in an AAALAC-accredited
animal facility at Lexicon Pharmaceuticals, Inc. (accreditation unit
#001025). Mice were housed in a barrier facility at 22uCo na
Figure 6. Absence of Rpn13 results in abnormal sexual
development. Testes and ovaries from mice of indicated genotype
and age were subjected to H&E staining. Arrows point to the following
features: 1. Maturing sperms in the tubular lumen of the Rpn13
+/+ testis
which are absent in the Rpn13
2/2 section, and Leydig cell clusters
present in both sections of 12-weeks old mice; 2. Spermatids and
spermatogonia in the Rpn13
+/+ testis are largely missing from Rpn13
2/2
mice, and hypertrophic Sertoli cells in the Rpn13
2/2 testes of 3-weeks
old mice; 3. Primordial follicles with ova and granulose cells present
only in the Rpn13
+/+ ovary, and replaced by interstitial stroma in the
Rpn13
2/2 ovary of 12-weeks old mice; 4. Ova which are numerous in Wt
and few in Rpn13
2/2 mice at 3-weeks of age.
doi:10.1371/journal.pone.0013654.g006
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water and standard rodent chow (9F 5021; Purina, St Louis, MO).
Procedures involving animals were conducted in conformity with
the Institutional Animal Care and Use Committee guidelines that
are in compliance with the state and federal laws and the standards
outlined in the Guide for the Care and Use of Laboratory
Figure 7. Deletion of Rpn13 alters T-cell development. (A) Hematopoietic cell profile of the indicated tissues harvested from mice with
genotypes designated on the figure. Data were obtained from 4–5 month old mice (n=15–31) and are presented as mean 6 SEM. Numbers above
bars indicate P values compared to Wt mice. Mono, monocytes; Neutro, neutrophils. (B) Representative picture of thymi from mice of indicated
genotype demonstrating difference in size of the organs. (C) Representative flow cytometric plots show normal CD4/CD8 mAb staining patterns of
thymocytes from mice of both genotypes. Samples from 10 additional mice of each genotype gave similar results.
doi:10.1371/journal.pone.0013654.g007
Figure 8. Rpn13 is essential for normal hormonal homeostasis. (A) Serum concentration of the indicated hormones was measured in the
mice designated on the figure. Data were pooled from at least three independent experiments giving similar results. Minimum 4, maximum 24 mice
were studied in each group, and only male mice were used for testosterone measurements. Data are presented as in Figure 7A. (B) Expression of GH
receptor and control GAPDH in the testes of mice with the indicated genotype. Western blot analysis was performed with the antibodies designated
on the figure.
doi:10.1371/journal.pone.0013654.g008
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Animal Care and Use Committee of Lexicon Pharmaceuticals,
Inc. (approved protocol permit numbers 054, 125 and 162). Unless
otherwise indicated, all experiments were carried out on 10- to 16-
week-old mice of mixed genetic background (129/SvEvBrd and
C57BL/6J) representing both sexes of littermate mutant and Wt
animals. For presentation of data, the age of mice was rounded to
the nearest week.
Expression analysis for gene transcripts
Total RNA was extracted from mouse tissues using a bead
homogenizer (BioSpec Products, Inc., Bartlesville, OK) and Trizol
reagent (Invitrogen, Carlsbad, CA) according to the manufactur-
er’s instructions. Reverse transcription (RT) was performed to
produce cDNA using 5 mg total RNA with SuperScript II
(Invitrogen) and random hexamer primers, according to the
manufacturer’s instructions. The same amount of water was
substituted for enzyme as control for genomic contamination.
PCR amplification was performed using 1 ml of the RT product at
initial denaturing step of 95uC for 2.5 min followed by 30 cycles of
95uC (30 sec), 59uC (20 sec), 70uC (1 min) with oligonucleotide
primers complementary to Rpn13 (G: 59-ACT ACG GTC ACC
CCA GAT AAA CGG AAA G-39and H), Uch37 (N: 59- TGT
CTC ATG GAA AGC GAC CC-39 and M: 59- GCC ACT TGA
AAA GAA AAA TTA ACC C-39), Rgs2 (59- GAT TGG AAG
ACC CGT TTG AGC TAC T-39 and 59- TGG GCA ATC AGA
GAT TTC GTT TGG A-39) and Trov2 (59- GAA AGT GAA
GCG CAC GAA AGA CGA C-39 and 59- GGC ACT GAC GTC
AAC AGC GAG CAA G-39). For analysis of Laminin, alpha 5
(Lama5, accession number XM_203796) and oxysterol binding
protein-like 2 (Osbpl2, accession number NM_144500) expression,
5 ml of a 1:7.5 diluted RT product was used. PCR was performed
at an initial denaturation step of 95uC for 2.5 min followed by 35
cycles of 95uC (30 sec), 60uC (30 sec), and 72uC (60 sec) with
oligonucleotide primers complementary to Lama5 (59- AAT GGG
CAG ATC TCT GTT CGT GAA G-39 and 59-CAT AGT AGG
TGC TGG GCA GTA GGA C-39) and Osbpl2 (59-TGG AGA
GAA TGC AGT CTG TCG C-39 and 59-CAC TCT GTC CAC
TTG CCA TAC ATG A-39). Primers to the mouse b-actin
(GenBank accession number M12481; 59-GGC TGG CCG GGA
CCT GAC GGA CTA CCT CAT-39 and 59-GCC TAG AAG
CAC TTG CGG TGC ACG ATG GAG-39 or 59- GAC CTT
CAA CAC CCC AGC CAT GTA-39 and 59- GCA CTG TGT
TGA CAT AGA GGT CTT TA-39) and GAPDH (NM_008084;
59-GGA AAG CTG TGG CGT GAT GG-39 and 59-ACC CTG
TTG CTG TAG CCG TAT TCA T-39) genes were also included
as internal controls for sample handling. PCR products were run
on a 2.5% agarose gel along with a 100 bp ladder. Gene specific
bands were verified by nucleotide sequencing.
Histological analysis
Freshly isolated tissues and embryos were immersion-fixed in
10% neutral buffered formalin, embedded in paraffin, sectioned at
4 mm, and stained with H&E on glass slides (Superfrost Plus; Fisher
Scientific, Pittsburgh, PA). IHC on tissues was done as described
previously [43]. The anti-Rpn13 mAb used in this study was
generated by immunizing Rpn13
2/2 mice intraperitoneally with
purified GST-Rpn13 protein in Freund’s adjuvant. Spleens from
high titer mice were harvested following a final intravenous boost
with purified GST-Rpn13 and splenocytes were fused with NS1
myeloma cells. Rpn13-specific hybridomas were identified by
ELISA screening of hybridoma culture supernatants on immobi-
lized GST-Rpn13 and counterscreened against GST alone to
confirm specificity for Rpn13. Rpn13-specific hybridomas were
subcloned by limiting dilution to ensure monoclonality. The mAb
used in this study was purified from scaled hybridoma culture
supernatant by protein A affinity chromatography.
Proteasome activity assays
Frozen tissues were lysed for 20 min at 4uC in buffer containing
10 mM Tris (pH 7), 25 mM KCl, 1.1 mM MgCl2, 0.1 mM
EDTA, 35% glycerol, 1 mM DTT, 1 mM sodium azide, 2 mM
adenosine triphosphate, 0.5% Triton X-100, and 16 protease
inhibitor cocktail (Sigma Aldrich, St. Louis, MO). Lysates were
cleared by centrifugation at 13,000 rpm for 10 min at 4uC, and
then the protein concentration of supernatants were adjusted to
1 mg/ml based on measurements with a BCA kit (Pierce,
Rockford, IL). Proteasome activities were measured using 10 ml
aliquots of supernatants in a Proteasome Glo
TM assay system
(Promega, Madison, WI), according to the manufacturer’s
instructions. 0.5 mg of purified 26S proteasome (Biomol, Plymouth
Meeting, PA) in 10 ml lysis buffer was incubated with and without
50 mM epoxomicin (Sigma Aldrich) for 1 hr at 4uC, and used as
negative and positive control, respectively.
Nuclear magnetic resonance (NMR) and CAT-scan
analysis
Non-invasive body fat measurements of anesthetized mice were
performed with a Minispec NMR Analyzer (Bruker minispec US,
The Woodlands, TX) and a MicroCAT scanner (ImTek, Inc.,
Knoxville, TN) using the manufacturers’ software. For the CAT-
scan, mice were injected intraperitoneally with 0.25 ml contrast
agent Omnipaque 300 (Nycomed Amersham, Norway).
Complete blood cell count (CBC) and flow cytometry
(FACS)
Blood was withdrawn from the retro-orbital plexus. CBC
analysis was performed using a HemaVet 850 FS (Drew Scientific,
Inc., Oxford, CT) instrument. For FACS analysis of whole blood,
red blood cells were lysed by hypotonic shock, after which
mononuclear cells were washed once in FACS buffer (PBS/0.1%
BSA/0.1% NaN3/2 mM EDTA), stained for 30 min at 4uC in the
dark with fluorochrome-conjugated mAbs, and washed prior to
analysis. Single-cell suspensions of thymus and spleen were stained
as above except that prior to staining, Fc receptors were blocked
for 15 min at 4uC with anti-CD16/CD32 mAbs (Fc Block, BD
Biosciences, San Diego, CA). Samples were analyzed using a
FACSCalibur flow cytometer and CellQuest Pro software (Becton
Dickinson Immunocytometry Systems, San Jose, CA).
The following rat mAbs were used in this study (all purchased
from BD Bioscience): anti-CD4-FITC, CD8a-PE, CD19-FITC,
CD45-PERCP, CD49b (pan-NK)-PE, and anti-TCRb-APC. In
the peripheral blood, B cells were identified as CD19
+/CD45
+/
TCRb
2/CD49b
2 mononuclear cells (MNC), T cells as CD4
+ or
CD8
+ and b
+/CD45
+/CD19
2 MNC, NK cells as CD49b
+/
CD45
+/CD19
2/TCRb
2 MNC, and monocytes as CD11b
+/
CD45
+/TCRb
2/CD19
2 MNC. The absolute number of each
cell subset was calculated by multiplying its fractional represen-
tation determined by FACS by the absolute number of MNC
identified by CBC.
Measurement of hormone concentration
Serum was isolated from retro-orbital blood by centrifugation at
2000 rpm for 5 min. Growth hormone (GH), testosterone and
cortisol concentrations were measured by ELISA (Alpha-
Diagnostics, San Antonio, TX). Serum follicular stimulating
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(Gaithersburg, MD).
Western blotting
15 mg of protein lysates were electrophoresed on 4–12% Tris-
Glycine gradient mini gels and proteins were transferred to
nitrocellulose membranes (all from Invitrogen). TBS-SuperblockH
was used to saturate the membranes and to dilute antibodies
(Pierce, Rockford, IL). Specific protein bands were identified using
rabbit primary antibodies to the GH receptor (Santa Cruz
Biotechnology, Santa Cruz, CA) and GAPDH (Bethyl Laborato-
ries, Montgomery, TX), and a secondary goat anti-rabbit antibody
conjugated with horseradish peroxidase (Bethyl Laboratories).
Membranes were washed in TBS-Tween (25 mM Tris-HCl,
pH 7.8, 190 mM NaCl, 0.1% Tween 20) between the incubation
periods. Western blots were developed by using an ECL detection
system (GE Life Sciences, Pittsburgh, PA) following the manufac-
turer’s directions.
Assessment of T cell receptor (TCR) repertoire
TCR diversity in thymocytes and splenocytes was assessed as
previously described [45].
Statistical analyses
Statistical analysis of the offspring ratios of genotypes employed
chi-square test. For other data, statistical significance of group
differences was evaluated by the unpaired, two-tailed, Student’s t
test. A p value of ,0.05 was considered significant.
Supporting Information
Figure S1 Analysis of the TCR alpha and beta chain repertoire
does not indicate clonal expansion of specific thymocyte subsets in
Rpn13
2/2 mice. RNA extracted from the indicated tissues of mice
with the designated genotype was subjected to RT-PCR specific to
the TCR-alpha and TCR-beta variable regions shown on the
figure.
Found at: doi:10.1371/journal.pone.0013654.s001 (0.42 MB TIF)
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